MedPath

To Improve the Clinical Outcome of Ultrasound-guided Radiofrequency Ablation by NAVIRFA® Navigation System.

Not Applicable
Recruiting
Conditions
Radiofrequency Ablation
Interventions
Device: NAVIRFA® Navigation System
Device: ultrasound
Registration Number
NCT05818176
Lead Sponsor
National Taiwan University Hospital
Brief Summary

Ultrasonic-guided radiofrequency ablation is the most common minimally invasive treatment for liver cancer. This study will use my country's self-developed intelligent ultrasonic navigation tool (NAVIRFA® Navigation System) to assist in the puncture of the needle during ablation, to observe the operation time, Whether the needle accuracy, ablation effect and complications are different from the traditional free-hand ultrasonic guidance technology.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria
  1. Patients with malignant liver tumors less than three centimeters in size who are expected to suffer radiofrequency tumor ablation in the hospital.
  2. At least 20 years old.
Exclusion Criteria
  1. Patients with abnormal coagulation function and low platelets are not suitable for ablation therapy after evaluation by the trial host.
  2. Those who are unable to accept computerized tomography and MRI examinations, such as poor renal function or contrast agent allergy, are not suitable for examination after the evaluation of the test host.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
NAVIRFA® Navigation SystemNAVIRFA® Navigation System-
ultrasound-guidedultrasound-
Primary Outcome Measures
NameTimeMethod
required scan timeBefore ablation treatment

the time required until start of the ablation (measured from the time of the first US scan to the start of the ablation).

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

National Taiwan University Hospital

🇨🇳

Taipei, Taiwan, Taiwan

© Copyright 2025. All Rights Reserved by MedPath